HDAC9 and acute myeloid leukemia: Therefore, HDAC inhibitors represent a promising treatment for patients with AML with t(8;21), as they may enhance histone acetylation via inhibition of HDAC activities, thus restoring the disrupted gene transcripts in AML (8).